A Neuroimaging study of Psilocybin in Depression
This study is recruiting in Canada. It is testing randomized Neuroimaging Trial of Psilocybin for depression.
In Toronto
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in Canada. It is testing randomized Neuroimaging Trial of Psilocybin for depression.
In TorontoThis study is recruiting in the United States. It focuses on depression.
In Los AngelesThis study is recruiting in the United States. It is testing azetukalner for depression in bipolarity.
Multiple locations, including TucsonThis study is recruiting in the United States. It is testing azetukalner for depression.
Multiple locations, including PhoenixThis study is recruiting in the United States, in Finland, in Poland, .... It is testing azetukalner for depression.
Multiple locations, including DothanThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in Uganda. It focuses on Schizophrenia.
In UgandaThis study is recruiting in Argentina. It focuses on Anxiety.
In ArgentinaThis study is recruiting in Bosnia and Herzegovina. It focuses on Schizophrenia.
In Bosnia and HerzegovinaThis study is recruiting in Bosnia and Herzegovina. It focuses on Anxiety.
In Bosnia and HerzegovinaThis study is recruiting in Bosnia and Herzegovina. It focuses on Schizophrenia.
In Bosnia and HerzegovinaThis study is recruiting in Colombia. It focuses on Schizophrenia.
In ColombiaHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.